SCEMOD
LIVE
Serial Number
79360497
Owner
INDIA GLYCOLS LIMITEDAttorney
Alexander LazouskiFiling Date
Sep 15, 2022
SCEMOD Trademark
Serial Number: 79360497 • Registration: 7301595
SCEMOD is a trademark filed by
INDIA GLYCOLS LIMITED
on September 15, 2022. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Alexander Lazouski LAZOUSKI IP LLC
SUITE 1
14726 BOWFIN TER.
LAKEWOOD RANCH
FL 34202
Trademark Details
Filing Date
September 15, 2022
Registration Date
February 13, 2024
Published for Opposition
November 28, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 11, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 16, 2024 FICS
FINAL DISPOSITION PROCESSED
May 16, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 13, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 13, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 28, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Nov 27, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 8, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 8, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 23, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 18, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 8, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 8, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 4, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jul 3, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 27, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 24, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 20, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 19, 2023 REPR